Bliss GVS Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma Limited has submitted a routine regulatory compliance certificate confirming that all securities received for dematerialisation during Q4 FY26 (January-March 2026) were properly processed by their Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The certificate verifies that physical share certificates were mutilated and cancelled, and depository names were substituted in the register of members within prescribed timelines. This is a mandatory quarterly filing under SEBI regulations governing depositories and participants.
No direct impact on shareholders or stock price. This is a routine compliance filing confirming proper processing of dematerialisation requests during the quarter, with no material corporate or financial implications.